On July 1, 2020, there will be several changes to the National Immunisation Program (NIP):

Eligibility for free NIP pneumococcal vaccines (Prevenar 13®, Pneumovax 23®)

  • Ceasing Pneumovax 23® for healthy non-Indigenous adults at 65 years of age
  • Commencing Prevenar 13® for healthy non-Indigenous adults ≥70 years of age
  • Commencing Prevenar 13® for Indigenous adults at ≥50 years of age plus Pneumovax 23® x 2 doses in a lifetime
  • Commencing Prevenar 13® for >12 months of age (including adolescents and adults) with newly diagnosed risk conditions plus Pneumovax 23® x 2 doses in a lifetime
  • New eligibility criteria for risk conditions

Eligibility for free NIP meningococcal B (Bexsero®) vaccine:

  • Aboriginal and Torres Strait Islander infants receive 2 primary doses of Bexsero® and 1 booster dose – 2, 4 and 12 months of age
  • Bexsero® catch-up is available for all Aboriginal and Torres Strait Islander children <2 years of age for 3 years until 30 June 2023
  • Some people with risk conditions will be eligible for Bexsero®

Read more about the changes here:

Clinical update: National Immunisation Program (NIP) schedule changes from 1 July 2020 – advice for vaccination providers